What does CUSIP 14757U208 represent in this 13F holders report?

CUSIP 14757U208 is the security identifier for CASI - CASI PHARMACEUTICALS INC - COM NEW used to aggregate holder disclosures.

How many institutions held CASI - CASI PHARMACEUTICALS INC - COM NEW in Q3 2022?

16 institutional investors reported CASI - CASI PHARMACEUTICALS INC - COM NEW for Q3 2022. Use the holders table for investor-level position and value details.

CASI PHARMACEUTICALS INC - COM NEW (CASI)

CUSIP: 14757U208

Q3 2022 13F Holders as of 30 Sep 2022

Security type / class: Equity / COM NEW
Total 13F shares: 1,623,229
Total 13F value: $4,221,348
Share change: -205,799
SEC-reported price per share: $2.60
Number of holders: 16
Value change: -$585,740
Number of buys: 7
Number of sells: 10

Security key

14757U208

Report period

Q3 2022

Institutions

Top holders

CASI full security history Ownership snapshot Full 13F holder table CASI Pharmaceuticals, Inc. SEC filings CASI Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CASI - CASI PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FEDERATED HERMES, INC.

Disclosed value leader

FEDERATED HERMES, INC.

Comparable rows

0/15

Latest evidence

30 Jun 2022

13F Highest disclosed value: $2,903,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FEDERATED HERMES, INC. has the largest disclosed position value at $2.9M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FEDERATED HERMES, INC.'s linked filing trail.

Disclosed position value Top 5

FEDERATED HERMES, INC. $2.9M

VANGUARD GROUP INC $875K

Wellington Shields Capital Manage... $610K

Wellington Shields & Co., LLC $416K

Ikarian Capital, LLC $378K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FEDERATED HERMES, INC.	13F Company 13F	— denominator unverified	$2,903,000 1,015,000 shares	—	30 Jun 2022
VANGUARD GROUP INC	13F Company 13F	— denominator unverified	$875,000 306,132 shares	—	30 Jun 2022
Wellington Shields Capital Management, LLC	13F Company 13F	— denominator unverified	$610,000 213,250 shares	—	30 Jun 2022
Wellington Shields & Co., LLC	13F Company 13F	— denominator unverified	$416,000 145,317 shares	—	30 Jun 2022
Ikarian Capital, LLC	13F Company 13F	— denominator unverified	$378,000 132,014 shares	—	30 Jun 2022
GEODE CAPITAL MANAGEMENT, LLC	13F Company 13F	— denominator unverified	$329,000 115,194 shares	—	30 Jun 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,623,229

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders

Q3 2022 holders

Holder diff

Investor	Q2 2022 Shares	Q3 2022 Shares	Share Diff	Share Chg %	Q2 2022 value	Q3 2022 value	Value change	Value Chg %